Article

Biological Therapy for Chronic Obstructive Pulmonary Disease (COPD): Efficacy and Safety

2025-10-19

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The predominant airway inflammation in chronic obstructive pulmonary disease (COPD) is neutrophilic, although numerous studies have shown that eosinophilic inflammation contributes significantly to COPD. Eosinophilic COPD patients are characterized by a greater number of total exacerbations and higher hospitalization rates. Biological therapy targets multiple steps in eosino...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 69154424-ae22-55f7-98ce-ddbfca3e155b
DOI: 10.1101/2025.10.17.25337825

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Biological Therapy for Chronic Obstructive Pulmonary Disease (COPD): Efficacy and SafetyDOI 10.1101/2025.10.17.25337825Read

Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase.Semantic proximity Read

Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.Semantic proximity Read

Chronic obstructive pulmonary disease: getting it right. Does optimal management of chronic obstructive pulmonary disease alter disease progression and improve survival?Semantic proximity Read

Chronic obstructive pulmonary disease.Semantic proximity Read

Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on Stable Chronic Obstructive Pulmonary disease:study protocol of a randomized, double-blind, placebo-controlled trialSemantic proximity Read

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol.Semantic proximity Read

Efficacy of Biologics in Aspirin Exacerbated Respiratory Disease: A Narrative ReviewSemantic proximity Read

Recommendations for COPD management in Central and Eastern Europe.Semantic proximity Read

Efficacy and Safety of Modified Bushen Yiqi Formulas(MBYF) as Add-On To Formoterol and Budesonide in The Management of COPD: Study Protocol for A Multi-Center, Double-Blinded, Placebo-Controlled, Parallel-Group, Randomized Clinical TrialSemantic proximity Read

Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic PhenotypeSemantic proximity Read

Precision medicine in COPD: where are we and where do we need to go?Semantic proximity Read

Safety Analysis of Biologic Therapies for Chronic Obstructive Pulmonary Disease: A Real-World Study Based on the FAERS DatabaseSemantic proximity Read